(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SATMOBO

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SATMOBO

ST13

US500000079424973

Class

5

Filing

79424973

Registration

8217515

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

11

Latest update

05/22/2026

Trademark type

Word

Nice classes

5

Filing date

04/22/2025

Registration date

04/21/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/21/2026

Last transaction

05/22/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

JP

Examiner

TRUSILO, KELLY JEAN

Law office

L70

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

TAIHO PHARMACEUTICAL CO., LTD.

Representatives

No representative data.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorderspharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the bloodpharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations

Publications

History of USPTO decisions and trademark events.

11 publications found

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/21/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

04/21/2026

PUBO

PUBLISHED FOR OPPOSITION

03/03/2026

NPUB

NOTICE OF PUBLICATION

02/25/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/06/2026

DOCK

ASSIGNED TO EXAMINER

01/29/2026

MAFR

APPLICATION FILING RECEIPT MAILED

01/28/2026

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/28/2026

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

07/04/2025

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

06/05/2025

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

05/29/2025

Continuous trademark protection

Get notified about every new filing that threatens SATMOBO or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.